Bonfa E - Search Results

1

Lupus in Latin-American patients: lessons from the GLADEL cohort.

Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL. Pons-Estel GJ, et al. Among authors: bonfa e. Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Lupus. 2015. PMID: 25697768 Review.

2

Lipoprotein(a) levels in systemic lupus erythematosus.

Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhão RC. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 1994 Feb;21(2):220-3. J Rheumatol. 1994. PMID: 8182628

3

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 1997;6(6):533-9. doi: 10.1177/096120339700600610. Lupus. 1997. PMID: 9256312

4

Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus.

Viana VS, Garcia S, Nascimento JH, Elkon KB, Brot N, Campos de Carvalho AC, Bonfá E. Viana VS, et al. Among authors: bonfa e. Lupus. 1998;7(3):141-7. doi: 10.1191/096120398678919895. Lupus. 1998. PMID: 9607636

5

Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.

Pasoto SG, Mendonça BB, Bonfá E. Pasoto SG, et al. Among authors: bonfa e. Lupus. 2002;11(3):175-80. doi: 10.1191/0961203302lu163oa. Lupus. 2002. PMID: 11999882

6

The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus.

Hayata AL, Borba EF, Bonfá E, Kochen JA, Goldenstein-Schainberg C. Hayata AL, et al. Among authors: bonfa e. Lupus. 2005;14(8):613-7. doi: 10.1191/0961203305lu2177oa. Lupus. 2005. PMID: 16175933

7

Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.

Fialho SC, Bonfá E, Vitule LF, D'Amico E, Caparbo V, Gualandro S, Pereira RM. Fialho SC, et al. Among authors: bonfa e. Lupus. 2007;16(4):239-44. doi: 10.1177/0961203307076771. Lupus. 2007. PMID: 17439929

8

Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.

Sachet JC, Borba EF, Bonfá E, Vinagre CG, Silva VM, Maranhão RC. Sachet JC, et al. Among authors: bonfa e. Lupus. 2007;16(4):273-8. doi: 10.1177/09612033070160040901. Lupus. 2007. PMID: 17439934 Clinical Trial.

9

Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus.

Kuruma KA, Borba EF, Lopes MH, de Carvalho JF, Bonfá E. Kuruma KA, et al. Among authors: bonfa e. Lupus. 2007;16(5):350-4. doi: 10.1177/0961203307078225. Lupus. 2007. PMID: 17576737 Clinical Trial.

10

Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus.

Febronio MV, Pereira RM, Bonfa E, Takiuti AD, Pereyra EA, Silva CA. Febronio MV, et al. Among authors: bonfa e. Lupus. 2007;16(6):430-5. doi: 10.1177/0961203307079298. Lupus. 2007. PMID: 17664234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters